Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Health

"Valentia Biopharma S.L. - Product Pipeline Review - 2013" now available at Fast Market Research


Print article Print article
2014-01-27 08:42:46 - New Pharmaceuticals market report from Global Markets Direct: "Valentia Biopharma S.L. - Product Pipeline Review - 2013"

Global Market Direct's pharmaceuticals report, "Valentia Biopharma S.L. - Product Pipeline Review - 2013" provides data on the Valentia Biopharma S.L.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Valentia Biopharma S.L.'s corporate website, SEC filings, investor presentations and featured press releases, both from Valentia Biopharma S.L. and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

* Valentia Biopharma S.L. - Brief Valentia Biopharma S.L. overview including business description, key information and facts, and its locations and subsidiaries.
* Review of current pipeline of Valentia Biopharma

S.L. human therapeutic division.
* Overview of pipeline therapeutics across various therapy areas.
* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
* Product profiles for late stage and clinical stage products of Valentia Biopharma S.L. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
* Recent updates of the Valentia Biopharma S.L.'s pipeline in the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.

Full Report Details at
- www.fastmr.com/prod/769524_valentia_biopharma_sl_product_pipelin ..

Reasons to Get this Report

* Evaluate Valentia Biopharma S.L.'s strategic position with total access to detailed information on its product pipeline.
* Assess the growth potential of Valentia Biopharma S.L. in its therapy areas of focus.
* Identify new drug targets and therapeutic classes in the Valentia Biopharma S.L.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
* Exploit collaboration and partnership opportunities with Valentia Biopharma S.L..
* Avoid Intellectual Property Rights related issues.
* Explore the dormant and discontinued projects of Valentia Biopharma S.L. and identify potential opportunities in those areas.

Report Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Valentia Biopharma S.L. Snapshot
Valentia Biopharma S.L. Overview
Key Information
Key Facts
Valentia Biopharma S.L. - Research and Development Overview
Key Therapeutic Areas
Valentia Biopharma S.L. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Valentia Biopharma S.L. - Pipeline Products Glance
Valentia Biopharma S.L. - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Valentia Biopharma S.L. - Drug Profiles
VLT-001
Product Description
Mechanism of Action
R&D Progress
VLT-002
Product Description
Mechanism of Action
R&D Progress
VLT-003
Product Description
Mechanism of Action
R&D Progress
VLT-004
Product Description
Mechanism of Action
R&D Progress
VLT-005
Product Description
Mechanism of Action
R&D Progress
Valentia Biopharma S.L. - Pipeline Analysis
Valentia Biopharma S.L. - Pipeline Products by Therapeutic Class
Valentia Biopharma S.L. - Pipeline Products by Route of Administration
Valentia Biopharma S.L. - Pipeline Products by Molecule Type
Valentia Biopharma S.L. - Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Valentia Biopharma S.L., Key Information
Valentia Biopharma S.L., Key Facts
Valentia Biopharma S.L. - Pipeline by Indication, 2013
Valentia Biopharma S.L. - Pipeline by Stage of Development, 2013
Valentia Biopharma S.L. - Monotherapy Products in Pipeline, 2013
Valentia Biopharma S.L. - Preclinical, 2013
Valentia Biopharma S.L. - Discovery, 2013
Valentia Biopharma S.L. - Pipeline by Therapeutic Class, 2013
Valentia Biopharma S.L. - Pipeline by Route of Administration, 2013
Valentia Biopharma S.L. - Pipeline by Molecule Type, 2013

List of Figures
Valentia Biopharma S.L. - Pipeline by Top 10 Indication, 2013
Valentia Biopharma S.L. - Pipeline by Stage of Development, 2013
Valentia Biopharma S.L. - Monotherapy Products in Pipeline, 2013
Valentia Biopharma S.L. - Pipeline by Top 10 Molecule Type, 2013

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.


Author:
Bill Thompson
e-mail
Web: www.fastmr.com
Phone: 18008448156

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com